Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Authors
Keywords
-
Journal
European Respiratory Review
Volume 29, Issue 155, Pages 190052
Publisher
European Respiratory Society (ERS)
Online
2020-02-12
DOI
10.1183/16000617.0052-2019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies
- (2019) Patrycja Pawlikowska et al. Journal of Thoracic Disease
- Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium
- (2019) B T Li et al. ANNALS OF ONCOLOGY
- Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
- (2019) Natasha B. Leighl et al. CLINICAL CANCER RESEARCH
- Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
- (2019) Guannan Kang et al. BMC CANCER
- Review: Microfluidics technologies for blood-based cancer liquid biopsies
- (2018) Yuxi Sun et al. ANALYTICA CHIMICA ACTA
- Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
- (2018) N Guibert et al. ANNALS OF ONCOLOGY
- The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues
- (2018) Nong Yang et al. BMC CANCER
- False positive plasma genotyping due to clonal hematopoiesis
- (2018) Yuebi Hu et al. CLINICAL CANCER RESEARCH
- Noninvasive detection of PD-L1 on circulating tumor cells in patient blood samples
- (2018) David AG Skibinski Future Oncology
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- (2018) Nicolas Guibert et al. LUNG CANCER
- Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping
- (2018) Nicolas Guibert et al. LUNG CANCER
- Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
- (2018) Christopher Abbosh et al. Nature Reviews Clinical Oncology
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer
- (2018) Manjima Dhar et al. Scientific Reports
- Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
- (2018) Galatea Kallergi et al. Therapeutic Advances in Medical Oncology
- Abstract 3407: A high performance target-enrichment strategy for liquid biopsy
- (2018) Jilong Liu et al. CANCER RESEARCH
- Abstract 5706: A blood-based next-generation sequencing assay to determine tumor mutational burden (bTMB) is associated with benefit to an anti-PD-L1 inhibitor, atezolizumab
- (2018) David Fabrizio et al. CANCER RESEARCH
- VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform
- (2018) Elodie Sollier-Christen et al. CYTOMETRY PART A
- Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer (NSCLC) using next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA).
- (2018) Nicolas Guibert et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
- (2018) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).
- (2018) Julien Mazieres et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
- (2018) Luc Cabel et al. Nature Reviews Clinical Oncology
- Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer
- (2018) Valsamo Anagnostou et al. CANCER RESEARCH
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study
- (2017) Christophe Massard et al. EUROPEAN JOURNAL OF CANCER
- Characterization of single circulating tumor cells
- (2017) Catherine Alix-Panabières et al. FEBS LETTERS
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
- (2017) Collin M Blakely et al. NATURE GENETICS
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
- (2017) Marius Ilie et al. Oncotarget
- Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma
- (2017) Nicolas Guibert et al. Oncotarget
- Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
- (2017) Sylvie Leroy et al. BMJ Open
- Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
- (2017) Kentaro Inamura Cancers
- Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
- (2017) Florence Koeppel et al. PLoS One
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
- (2016) S. Koyama et al. CANCER RESEARCH
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
- (2016) J. C. Thompson et al. CLINICAL CANCER RESEARCH
- A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial
- (2016) M. Yanagita et al. CLINICAL CANCER RESEARCH
- Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
- (2016) Tobias M. Gorges et al. CLINICAL CHEMISTRY
- Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis
- (2016) Avid Khamenehfar et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Comparison of PD-L1 expression between tumor tissues and circulating tumor cells in patients with lung cancer
- (2016) Y. Koh et al. EUROPEAN JOURNAL OF CANCER
- Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
- (2016) Geoffrey R. Oxnard et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF -Mutated Lung Adenocarcinoma
- (2016) Nicolas Guibert et al. Journal of Thoracic Oncology
- A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
- (2016) Karen L. Reckamp et al. Journal of Thoracic Oncology
- Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma
- (2016) Nicolas Guibert et al. LUNG CANCER
- The cellular origins of drug resistance in cancer
- (2016) Geoffrey R Oxnard NATURE MEDICINE
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
- (2016) J. F. Gainor et al. Cancer Discovery
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Early Intervention in Lung Cancers With Rapid Plasma Genotyping forEGFRandKRASMutations—Reply
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
- (2016) Chiara Nicolazzo et al. Scientific Reports
- Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
- (2015) Xuanzhang Huang et al. BMC CANCER
- Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
- (2015) T. K. Sundaresan et al. CLINICAL CANCER RESEARCH
- Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients
- (2015) C. P. Paweletz et al. CLINICAL CANCER RESEARCH
- Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
- (2015) Claire Tissot et al. EUROPEAN RESPIRATORY JOURNAL
- Importance of circulating tumor cells in newly diagnosed colorectal cancer
- (2015) GUUS VAN DALUM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Frequent expression of PD-L1 on circulating breast cancer cells
- (2015) Martine Mazel et al. Molecular Oncology
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Next-generation sequencing to guide cancer therapy
- (2015) Jeffrey Gagan et al. Genome Medicine
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
- (2014) S. Couraud et al. CLINICAL CANCER RESEARCH
- Detection of Circulating Tumor Cells from Lung Cancer Patients in the Era of Targeted Therapy : Promises, Drawbacks and Pitfalls
- (2014) V. Hofman et al. CURRENT MOLECULAR MEDICINE
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Marius Ilie et al. PLoS One
- Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
- (2014) Florent Mouliere et al. Translational Oncology
- Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
- (2014) Jie Luo et al. Scientific Reports
- EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients
- (2013) Umberto Malapelle et al. CANCER CYTOPATHOLOGY
- Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
- (2013) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Analysis and Interpretation of Cancer Genome Data
- (2013) Eliezer M. Van Allen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer
- (2013) Erik Folch et al. Journal of Thoracic Oncology
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Clinical application of amplicon-based next-generation sequencing in cancer
- (2013) Fengqi Chang et al. Cancer Genetics
- ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
- (2012) M. Ilie et al. ANNALS OF ONCOLOGY
- Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content
- (2012) Elena Y Rykova et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- (2012) Jian-Mei Hou et al. JOURNAL OF CLINICAL ONCOLOGY
- Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
- (2011) V. Hofman et al. CYTOPATHOLOGY
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- (2011) Matthew G. Krebs et al. Journal of Thoracic Oncology
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The virtosome-a novel cytosolic informative entity and intercellular messenger
- (2010) Peter B. Gahan et al. CELL BIOCHEMISTRY AND FUNCTION
- Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
- (2010) V. Hofman et al. CLINICAL CANCER RESEARCH
- Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis
- (2010) D. P. Steinfort et al. EUROPEAN RESPIRATORY JOURNAL
- Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
- (2010) Véronique Hofman et al. INTERNATIONAL JOURNAL OF CANCER
- Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients
- (2010) Chi Wu et al. Journal of Thoracic Oncology
- Malignant cells facilitate lung metastasis by bringing their own soil
- (2010) D. G. Duda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Collective cell migration in morphogenesis, regeneration and cancer
- (2009) Peter Friedl et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
- (2008) J.-Y. Pierga et al. CLINICAL CANCER RESEARCH
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search